Cahill Represents ICON plc in its Acquisition of Clinical Research Management, Inc.
Date: 09/19/16
Cahill represented ICON plc (NASDAQ: ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, in connection with its acquisition of Clinical Research Management, Inc. (ClinicalRM). ClinicalRM provides full service and functional research solutions to a broad range of U.S. government agencies. The acquisition extends ICON’s presence in the market for government sponsored research and enhances capabilities in vaccines and infectious disease.